Literature DB >> 3943790

Prognostic significance of serum bile acids in cirrhosis.

G A Mannes, C Thieme, F Stellaard, T Wang, T Sauerbruch, G Paumgartner.   

Abstract

The value of serum bile acid concentrations for predicting prognosis in cirrhotics was compared with the prognostic significance of clinical and laboratory findings in a prospective 1-year study of 76 patients with cirrhosis. A commercial radioimmunoassay for total serum-conjugated primary bile acids was used. Of 76 patients, 16 died within the follow-up period. The concentration of bile acids in serum more closely correlated with mortality in cirrhosis than the commonly used clinical and laboratory parameters such as the Number Connection Test, ascites, albumin, pseudocholinesterase, bilirubin, prothrombin time and nutritional state. Serum bile acids alone yielded a prediction of mortality comparable to the Child classification. When logistic regression analysis was performed, optimal prediction of prognosis was achieved with the combination of serum bile acids and the Number Connection Test. Serum bile acid levels alone or in combination with the Number Connection Test may be a clinically useful prognostic index in cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943790     DOI: 10.1002/hep.1840060110

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.

Authors:  J Reichen; B Egger; N Ohara; T B Zeltner; T Zysset; A Zimmermann
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

2.  Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis.

Authors:  Xiaoning Wang; Guoxiang Xie; Aihua Zhao; Xiaojiao Zheng; Fengjie Huang; Yixing Wang; Chun Yao; Wei Jia; Ping Liu
Journal:  J Proteome Res       Date:  2016-03-22       Impact factor: 4.466

3.  Serum bile acids and oral ursodeoxycholic acid tolerance test in the diagnosis of esophageal varices.

Authors:  M Kadohara; H Kawasaki; C Hirayama
Journal:  Gastroenterol Jpn       Date:  1987-10

4.  Bile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease.

Authors:  William J Brock; James J Beaudoin; Jason R Slizgi; Mingming Su; Wei Jia; Sharin E Roth; Kim L R Brouwer
Journal:  Int J Toxicol       Date:  2018 Mar/Apr       Impact factor: 2.032

5.  Somatostatin does not reduce oesophageal variceal pressure in liver cirrhotics.

Authors:  G Kleber; T Sauerbruch; G Fischer; G Paumgartner
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

6.  Serum bile acid concentrations, histopathological features, and short-, and long-term survival in horses with hepatic disease.

Authors:  B Dunkel; S A Jones; M J Pinilla; A K Foote
Journal:  J Vet Intern Med       Date:  2015 Mar-Apr       Impact factor: 3.333

7.  Metabolic Profile of Obeticholic Acid and Endogenous Bile Acids in Rats with Decompensated Liver Cirrhosis.

Authors:  A Roda; R Aldini; C Camborata; S Spinozzi; P Franco; M Cont; A D'Errico; F Vasuri; A Degiovanni; L Maroni; L Adorini
Journal:  Clin Transl Sci       Date:  2017-05-23       Impact factor: 4.689

8.  Role of bile acids in the diagnosis and progression of liver cirrhosis: A prospective observational study.

Authors:  Ning Liu; Jiao Feng; Yang Lv; Qing Liu; Jingfan Deng; Yujing Xia; Chuanyong Guo; Yingqun Zhou
Journal:  Exp Ther Med       Date:  2019-09-17       Impact factor: 2.447

9.  Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors.

Authors:  Edana Cassol; Vikas Misra; Alexander Holman; Anupa Kamat; Susan Morgello; Dana Gabuzda
Journal:  BMC Infect Dis       Date:  2013-05-04       Impact factor: 3.090

10.  Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments.

Authors:  Zhimin Liu; Zhifeng Zhang; Mei Huang; Xiaoping Sun; Bojia Liu; Qiyang Guo; Qingshan Chang; Zhijun Duan
Journal:  BMC Gastroenterol       Date:  2018-07-11       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.